Title
CD1b Tetramers Broadly Detect T Cells That Correlate With Mycobacterial Exposure but Not Tuberculosis Disease State
Date Issued
14 February 2020
Access level
open access
Resource Type
journal article
Author(s)
Lopez K.
Iwany S.K.
Suliman S.
Reijneveld J.F.
Ocampo T.A.
Murray M.B.
Moody D.B.
Van Rhijn I.
Publisher(s)
Frontiers Media S.A.
Abstract
The non-polymorphic nature of CD1 proteins creates a situation in which T cells with invariant T cell receptors (TCRs), like CD1d-specific NKT cells, are present in all humans. CD1b is an abundant protein on human dendritic cells that presents M. tuberculosis (Mtb) lipid antigens to T cells. Analysis of T cell clones suggested that semi-invariant TCRs exist in the CD1b system, but their prevalence in humans is not known. Here we used CD1b tetramers loaded with mycolic acid or glucose monomycolate to study polyclonal T cells from 150 Peruvian subjects. We found that CD1b tetramers loaded with mycolic acid or glucose monomycolate antigens stained TRAV1-2+ GEM T cells or TRBV4-1+ LDN5-like T cells in the majority of subjects tested, at rates ~10-fold lower than NKT cells. Thus, GEM T cells and LDN5-like T cells are a normal part of the human immune system. Unlike prior studies measuring MHC- or CD1b-mediated activation, this large-scale tetramer study found no significant differences in rates of CD1b tetramer-mycobacterial lipid staining of T cells among subjects with Mtb exposure, latent Mtb infection or active tuberculosis (TB) disease. In all subjects, including “uninfected” subjects, CD1b tetramer+ T cells expressed memory markers at high levels. However, among controls with lower mycobacterial antigen exposure in Boston, we found significantly lower frequencies of T cells staining with CD1b tetramers loaded with mycobacterial lipids. These data link CD1b-specific T cell detection to mycobacterial exposure, but not TB disease status, which potentially explains differences in outcomes among CD1-based clinical studies, which used control subjects with low Mtb exposure.
Volume
11
Language
English
OCDE Knowledge area
Sistema respiratorio
Química medicinal
Enfermedades infecciosas
Subjects
Scopus EID
2-s2.0-85080840735
PubMed ID
Source
Frontiers in Immunology
ISSN of the container
16643224
Sponsor(s)
This work was supported by the National Institutes of Health (NIH) Tuberculosis Research Unit Network, Grant U19 AI111224-01, AI049313 and the Bill and Melinda Gates Foundation Vaccine Accelerator Award.
Sources of information:
Directorio de Producción Científica
Scopus